Mostafa Meshref: Find Our Research Contributions at ESOC 2026
Mostafa Meshref, Assistant Lecturer of Neurology in the Faculty of Medicine at Al-Azhar University, shared on LinkedIn:
”The European Stroke Organisation Congress 2026 (ESOC 2026) has concluded.
Despite being unable to attend in person, I had the wonderful honor to see our five accepted abstracts published online in the European Stroke Journal.
Three of those abstracts were accepted as e-poster presentations.
Additionally, these abstracts were previously published as full manuscripts.
You can read them as follows:
- Abstract number: ESOC2026A286 Clinical efficacy of combination therapy vs. Endovascular treatment alone in acute ischemic stroke: A retrospective study.
- Abstract number: ESOC2026A316 Postpartum vertebral artery dissection: clinical features, course, and outcomes in a pooled analysis of case reports.
- Abstract number: ESOC2026A245 Clinical outcomes following mechanical thrombectomy in hyperacute posterior circulation stroke.
Thanks to all team members and my colleagues and professors at my university.”
Title 1: Outcomes of endovascular treatment alone or with intravenous alteplase in acute ischemic stroke Patients: A retrospective cohort study
Authors: Mahmoud Galal Ahmed, Nour Shaheen, Ahmed Shaheen, Mostafa Meshref, Abdulqadir J. Nashwan, Nourelhuda Ahmed Nassar, Khaled Sobh
Title 2: Clinical Characteristics, Course, and Outcomes of Vertebral Artery Dissections in the Postpartum Period; a Pooled Analysis of Published Case Reports
Authors:Rehab Adel Diab, Nour Shaheen, Abdel-rahman Mohamed, Mahmoud Tarek Hefnawy, Dilawer Chofan Charo, Mostafa Meshref
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian